IMBiologics
- Biotech or pharma, therapeutic R&D
IMBiologics (IMB) focuses on developing novel treatment options for Immunology & inflammation (I&I) diseases and cancer, utilizing innovative mechanisms of action and/or diverse modalities including conventional IgG and multivalent antibody backbone technology, ePENDY.